The kick-off meeting for the RHU SPRINT hospital-university research project, Synergy to accelerate therapeutic innovation in cutaneous T lymphoma, took place on Monday May 27, 2024.
RHU SPRINT Kick-Off
The meeting was held at the Faculty of Health at Villemin, in the presence of the ANR and RHU partners.
© Skin cells. Credits: RHU SPRINT
RHU SPRINT Kick-off meeting, May 27, 2024
Under the aegis of the Agence Nationale de la Recherche (ANR), the partners in this project, for which Université Paris Cité is the coordinating institution, met on the premises of the Faculty of Health of Université Paris Cité at Villemin: APHP, Inserm, CHU de Bordeaux, HCL, Domain Therapeutics, TheraPanacea, the French study group of cutaneous lymphomas (GFELC), and the patient associations ELLyE and EuroBloodNet.
This afternoon of exchange was an opportunity to present the project from a scientific, administrative and financial angle, and to enable the partners to understand the expectations of the ANR, which is contributing 30% of the funding: €9,664,690, the total cost of the project being €29,821,757.
This was the first stage of a 5-year program led by Pr Adèle de Masson, PU-PH – Université Paris Cité / AP-HP, which aims to develop new diagnostic, prognostic and therapeutic tools for cutaneous T-cell lymphomas, in order to transform the future of patients suffering from these diseases, usually considered incurable.
We’ll be keeping you regularly updated on the progress of RHU SPRINT, to which a dedicated website will shortly be dedicated.
The RHU SPRINT has received government funding managed by the Agence Nationale de la Recherche under the France 2030 program, under the reference ANR-23-RHUS-0009.
À lire aussi
Podcast – Rare disease – Managing mycosis fongoides
Caroline Ram-Wolff, dermatologist in the dermatology department at Saint-Louis Hospital in Paris, medical coordinator of the GFELC Scientific Council, and member of the RHU SPRINT project, was recently a guest on the podcast RARE à l’écoute 🎤🧬, the first 100% rare disease-focused media outlet. In this third episode of the series dedicated to cutaneous T-cell lymphoma, she reviews the different management strategies for patients with mycosis fungoides
Podcast – Rare disease – How can mycosis fungoides be diagnosed?
In the second episode of the podcast RARE à l’écoute 🎤🧬 — the first media outlet entirely dedicated to rare diseases — Nicolas Ortonne, pathologist, team leader at the IMRB – Institut Mondor de Recherche Biomédicale, and member of the RHU SPRINT consortium, shares his experience and discusses the challenges involved in diagnosing mycosis fungoides.
Podcast – Rare disease – What is a mycosis fongoïde?
Martine Bagot, a member of the RHU SPRINT consortium and Professor of Dermatology at Université Paris Cité, was recently featured on the podcast RARE à l’écoute. On this occasion, she discussed mycosis fungoides, the most common form of cutaneous lymphoma.
RHU SPRINT NEWSLETTER N°2
Welcome to the RHU SPRINT newsletter! This page aims to keep you informed about the progress of the project, share key highlights, and showcase the contributions of all consortium members. Through these updates, we seek to provide a dynamic overview of ongoing work,...